In a recent study researchers observed notable pain relief in patients using topical cannabis for various inflammatory diseases.
The study was published in the journal Revista Alergia México and is available online through the United States National Library of Medicine.
The research aimed to explore the effectiveness of cannabis as a topical analgesic for patients diagnosed with conditions like arthrosis, unspecified, non-toxic multinodular goiter, epilepsy, chronic venous insufficiency, unspecified lumbago, secondary gonarthrosis, rotator cuff syndrome, and carpal tunnel syndrome. A total of 23 patients from Salud Social I.P.S were selected through non-probabilistic convenience sampling for this analytical, retrospective study.
“All patients showed pain relief after two months of follow-up, two experienced adverse effects”, claim researchers. “Some studies suggest that cannabinoids present in cannabis, such as CBD and THC, may have analgesic and anti-inflammatory properties that could alleviate pain and inflammation associated with these conditions. This is consistent with the present study.”
Researchers conclude by stating “Topical cannabis is presented as a therapeutic alternative in inflammatory diseases, however, it is important to highlight that research on the use of cannabis in these diseases is limited and more studies are needed to fully understand its effects and potential benefits.”
According to a separate study published in September, the topical administration of 1% CBD gel “is a potentially effective candidate for an anti-inflammatory agent”.
Topical marijuana may also promote hair growth in those with alopecia, according to a study published in July by the International Journal of Trichology.
